SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-029311
Filing Date
2015-05-11
Accepted
2015-05-11 16:35:27
Documents
12
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v408312_10q.htm 10-Q 558298
2 EXHIBIT 10.1 v408312_ex10-1.htm EX-10.1 237477
3 EXHIBIT 31.1 v408312_ex31-1.htm EX-31.1 11517
4 EXHIBIT 31.2 v408312_ex31-2.htm EX-31.2 11390
5 EXHIBIT 32.1 v408312_ex32-1.htm EX-32.1 3964
6 EXHIBIT 32.2 v408312_ex32-2.htm EX-32.2 3983
  Complete submission text file 0001144204-15-029311.txt   5161596

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tgtx-20150331.xml EX-101.INS 612236
8 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20150331.xsd EX-101.SCH 55013
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtx-20150331_cal.xml EX-101.CAL 34658
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20150331_def.xml EX-101.DEF 282793
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20150331_lab.xml EX-101.LAB 361839
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20150331_pre.xml EX-101.PRE 322534
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 15851266
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences